About us

Hetalox specializes in the development of advanced AI algorithms for neuroimaging analysis.

Hetalox is a medical technology company that provides artificial intelligence (AI) solutions for advanced assessment and analysis of brain MRI studies. Our core offerings are built upon advanced proprietary AI algorithms, which drive innovation and precision in medical technology. Supported by a distinct dataset and a seasoned team of professionals, Hetalox ensures cutting-edge solutions for advanced healthcare needs.

Our mission

We develop innovative solutions based on artificial intelligence (AI) for advanced assessment and analysis of brain MRI studies. This is our response to the growing demand for effective tools supporting the diagnosis and monitoring of the course of neurodegenerative and demyelinating diseases.


World Health Organization (WHO) estimates that the number of people living with dementia (with Alzheimer's disease being the most common form) is currently around 50 million worldwide, with nearly 10 million new cases every year.

Multiple sclerosis

Multiple sclerosis (MS), affects approximately 2.8 million people worldwide (with a higher prevalence among young women), requires long-term medical surveillance and treatment. The disease significantly diminishes the quality of life for both patients and their families, especially as it progresses to severe disability.

Impact of Hetalox

A comprehensive analysis system, such as Hetalox, is needed to enable:

Early detection of diseases

accurate and fast disease detection and screening to identify patients susceptible to diseases,

Monitoring disease progression

objective analysis and long-term monitoring to provide necessary information for selecting appropriate treatment methods,

Support for treatment decisions

immediate modification of therapy when necessary,

Improving quality of life

reduction of the social impact of the disease and improvement of people's quality of life worldwide.